You just read:

Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection

News provided by

Regeneron Pharmaceuticals, Inc.

Jan 05, 2017, 20:00 ET